Clinical Trials on Gastrointestinal Neoplasms in Ireland
Total 0 results
Nothing found
Sponsors and Collaborators
- Prader-Willi Syndrome Association of Australia
- wenbinlu
- The Depressive and Bipolar Disorder Alternative Treatment Foundation
- Remedy Institute
- Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
- Laboratoires Iprad-Vegebom
- Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
- NATURAmedicatrix Sàrl
- Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
- Carlos III Health Institute
- Sociedad Española de Arteriosclerosis
- Epicentre, Paris, France.
- Resurge Therapeutics Inc.
- Sonogenix
- Kettering Foundation
- Australian Childhood Foundation
- Paul W. Read, MD
- Zhijun Sun
- Brigham and Womens' Hospital, Center for Surgery and Public Health
- Health Holding Company, Hail Health Cluster, Saudi Arabia
- View Full List
Medical Conditions
- Psychoactive Substance Use
- Escape Room Games and Role Playing Gamification
- Neurobehavioral Manifestation
- Refractory B-Lineage Lymphoma
- Stage IIIB Esophageal Adenocarcinoma
- Hernia,Ventral
- Intervention Studies
- Pregnancy; Accident
- Marginal Zone B-cell Lymphoma
- Stage III Childhood Anaplastic Large Cell Lymphoma
- Cell Senescence
- Ankle Trauma
- Stroke Recrudescence
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Apneic; Oxygenation
- Lymphoblastic Lymphoma
- Spinocerebellar Ataxia Genotype Type 3
- Malignant Tumor of Extrahepatic Bile Duct
- Mycobacterium Avium Complex Infections
- Adherence to In-Office Glaucoma Evaluation Appointment
- View Full List
Drug Interventions
- Fostamatinib
- Oral Aztreonam
- 300 mg of caffeine citrate infusion
- Everolimus
- Irinotecan
- SBI-087
- Colecalciferol D3 (Vigantol Oil)
- ART-123
- Omeprazole 40 mg
- Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
- FRSW107
- LINjeta U-100 Insulin
- Epalrestat
- Fenofibric acid 135mg
- Gadoteridol (ProHance)
- Lansoprazole 15mg QD
- Optiva artificial tear by Allergan
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Low molecular weight Heparin as standard of care treatment
- Triple therapy
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Chile
- Contract Research Organizations in China
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Gambia
- Contract Research Organizations in Israel
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Malta
- Contract Research Organizations in Morocco
- Contract Research Organizations in Qatar
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Tanzania
- CRO list by country